PHOENIX, June 5, 2024
/PRNewswire/ -- Trinity Capital Inc. (NASDAQ: TRIN)
("Trinity"), a leading provider of diversified financial solutions
to growth-oriented companies, today announced the commitment of
$15 million in growth capital to
restor3d, a 3D printing, patient specific medical device
company.
restor3d enhances patient care and meets surgeons' needs by
providing solutions tailored to patients' unique anatomies,
enabling precise repair, reconstruction, and restoration. The
company holds proprietary expertise in advanced 3D printing of
osseointegrative materials, AI-based planning and design automation
tools, and digital health solutions to provide seamless data-backed
care to optimize individual patient outcomes.
"restor3d is at the forefront of innovation in the customized
orthopedic implant industry with its unique patient specific 3D
printed technologies," said Lauren
Cosentino, Managing Director, Life Sciences at Trinity. "We
look forward to working with restor3d's leadership team and
supporting the company's continued growth."
The new debt facility from Trinity will allow restor3d to
continue its product innovation and expansion into new markets.
"We are thrilled to partner with Trinity as we continue to scale
our business and bring our innovative, patient specific medical
devices to more surgeons and patients worldwide," said Kurt Jacobus, Chief Executive Officer of
restor3d. "This investment underscores the immense potential of our
technology to transform patient care and drive better surgical
outcomes."
About Trinity Capital Inc.
Trinity Capital Inc. (Nasdaq: TRIN), an internally managed
business development company, is a leading provider of diversified
financial solutions to growth-stage companies with institutional
equity investors. Trinity Capital's investment objective
is to generate current income and, to a lesser extent, capital
appreciation through investments, including term loans and
equipment financings and equity-related investments. Trinity
Capital believes it is one of only a select group of specialty
lenders that has the depth of knowledge, experience and track
record in lending to growth stage companies. For more information,
please visit the Company's website at www.trinitycap.com.
About restor3d, Inc.
restor3d is a world leader in patient specific musculoskeletal
implants and driven by the belief that every patient deserves
personalized care. The company holds proprietary expertise in 3D
printing of osseointegrative materials, AI-based planning and
design automation tools, and digital health solutions to provide
seamless data-backed care to optimize individual patient outcomes.
Alongside its customers, restor3d is reimagining the
musculoskeletal reconstruction landscape. More information is
available at www.restor3d.com.
View original content to download
multimedia:https://www.prnewswire.com/news-releases/trinity-capital-inc-provides-15-million-in-growth-capital-to-restor3d-302163928.html
SOURCE Trinity Capital Inc.